Sabinsa’s VP Scientific Affairs Anurag Pande PhD will give a presentation addressing the recent safety and efficacy studies on Sabinsa’s shelf-stable probiotic LactoSpore® at the Global Engage 4th Microbiome R&D And Business Collaboration Forum to be held in La Jolla, California October 3 – 4, 2016. Dr. Pande will also touch upon the clinical results on the company’s DigeZyme® multi-complex enzyme blend to be published later this year.

Only the Fittest Survive: Heat Stable LactoSpore® Probiotic
Tuesday October 4 at 10.20 am – 10.50 am

Sabinsa is also a Gold sponsor of the Forum, which is designed to “explore the interface between our evolving cultures, technologies and our microbiome through a series of interactive presentations and panel discussions with leading academics and industry experts as well as venture capital investors and leading solution, service and technology providers.”

Sabinsa can be visited at booth #17 during the conference for further insights.

“We’re proud to be associated with some of the leading research companies out there on the probiotic side,” said Sabinsa Marketing Director Shaheen Majeed. “With Dr. Pande’s presentation, attendees will see why only the fittest probiotic will survive, through stability and functionality.”